Methylene Blue Injection is indicated for the treatment of pediatric and adult patients with acquired methemoglobinemia.
From the U.S. FDA-approved label for Methylthioninium chloride (methylene blue). Full label: DailyMed.
Methylene Blue Injection is indicated for the treatment of pediatric and adult patients with acquired methemoglobinemia.
From the U.S. FDA-approved label for Methylthioninium chloride (methylene blue). Full label: DailyMed.
Administer 1 mg/kg intravenously over 5-30 minutes. If methemoglobin level remains above 30% or if clinical symptoms persist, give a repeat dose of up to 1 mg/kg one hour after the first dose. Administer a single dose of 1 mg/kg in patients with moderate or severe renal impairment.
Directions from the U.S. FDA-approved label — your doctor or pharmacist may advise differently.
Methylene blue injection is contraindicated in the following conditions: Severe hypersensitivity reactions to methylene blue or any other thiazine dye. Patients with glucose-6-phosphate dehydrogenase deficiency (G6PD) due to the risk of hemolytic anemia. Methylene blue injection is contraindicated in the following conditions: Severe hypersensitivity to methylene blue Patients with glucose-6-phosphate dehydrogenase deficiency (G6PD) due to the risk of hemolytic anemia
Excerpt from the U.S. FDA-approved label. Talk to a pharmacist or doctor before use.
Hypersensitivity: If severe or life threatening allergic reaction occurs, discontinue methylene blue injection, treat the allergic reaction, and monitor until signs and symptoms resolve. Lack of Effectiveness: Consider alternative treatments if there is no resolution of methemoglobinemia after 2 doses. Hemolytic Anemia: Discontinue methylene blue injection and transfuse. Interference with In Vivo Monitoring Devices: Use methods other than pulse oximetry to assess oxygen saturation.
Warnings and precautions excerpt from the U.S. FDA-approved label — not a complete list. Talk to a pharmacist or doctor before use.
The following adverse reactions are discussed in greater detail in other sections of the labeling: Serotonin Syndrome with Concomitant Use of Serotonergic Drugs Anaphylaxis Lack of Effectiveness Hemolytic Anemia Interference with In Vivo Monitoring Devices Effects on Ability to Drive and Operate Machinery Interference with Laboratory Tests The most commonly reported adverse reactions (≥2%) included headache, hypokalemia,…
Excerpt from the U.S. FDA-approved label — not a complete list. Talk to a pharmacist or doctor about side effects.
2 products from 2 makers in the NepalDoc medicine catalog use this generic:
| Brand | Composition | Maker | Pack |
|---|---|---|---|
| Blue Beam Injection | Methylene Blue (10mg/ml) | Flagship Biotech International | ampoule of 10 ml Injection |
| Sam MB 10mg Injection | Methylene Blue (10mg) | Samarth Life Sciences Pvt Ltd | vial of 1 Injection |
Brand list from the NepalDoc medicine catalog. Availability varies by pharmacy — call ahead to confirm stock.
Store at 20° to 25°C (68° to 77°F); excursions permitted to 15° to 30°C (59° to 86°F). Any unused product or waste material should be disposed of in accordance with local practice. Do not refrigerate or freeze. Keep the vial in the original package to protect from light. The container closure is not made with natural rubber latex.
Storage information from the U.S. FDA-approved label.
This page is information only and is not medical advice. Medicine details come from the sources listed above and may change — always confirm the medicine, strength and dose with a pharmacist or doctor before use. NLEM listing does not guarantee that a medicine is in stock at any pharmacy.
